Skip to main content

GlaxoSmithKline-gsk-logo

Confucius says “To Get Bigger Sometimes You Must Be Smaller.” Alright, so I made that up but that seems to be the thinking behind GlaxoSmithKlein’s (GSK – Analyst Report)  move to sell two meningitis vaccines to rival Pfizer (PFE – Analyst Report), in order to satisfy antitrust concerns after GSK’s recent acquisition of the vaccine business from Novartis. Sound confusing? Well it is.

{iframe}http://www.zacks.com/stock/news/179321/gsk-vaccinates-pfizer-to-gain-novartis{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.